INSULET CORPORATION Underwriting AgreementUnderwriting Agreement • June 28th, 2011 • Insulet Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledJune 28th, 2011 Company Industry JurisdictionInsulet Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), $125,000,000 principal amount of its 3.75% Convertible Senior Notes due 2016 (the “Underwritten Securities”) and, at the option of the Underwriters, up to an additional $18,750,000 principal amount of its 3.75% Convertible Senior Notes due 2016 (the “Option Securities”) if and to the extent that the Underwriters shall have determined to exercise the option to purchase such 3.75% Convertible Senior Notes due 2016 granted to the Underwriters in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash, shares (the “Underlying Securities”) of common stock of the Company, par value $0.001 per share (the “Common Stock”) or a combination thereof at the Company’s election
HEARTWARE INTERNATIONAL, INC. Underwriting AgreementUnderwriting Agreement • December 15th, 2010 • HeartWare International, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 15th, 2010 Company Industry JurisdictionHeartWare International, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), $125 million principal amount of its 3.50% Convertible Senior Notes due 2017 (the “Underwritten Securities”) and, at the option of the Underwriters, up to an additional $18.75 million principal amount of its 3.50% Convertible Senior Notes due 2017 (the “Option Securities”) if and to the extent that the Underwriters shall have determined to exercise the option to purchase such 3.50% Convertible Senior Notes due 2017 granted to the Underwriters in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities.” The Securities will be convertible into cash, shares (the “Underlying Securities”) of common stock of the Company, par value $0.001 per share (the “Common Stock”) or a combination thereof at t
EXTERRAN HOLDINGS, INC. 4.25% Convertible Senior Notes due 2014 Underwriting AgreementUnderwriting Agreement • June 10th, 2009 • Exterran Holdings Inc. • Services-equipment rental & leasing, nec • New York
Contract Type FiledJune 10th, 2009 Company Industry JurisdictionExterran Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $325,000,000 principal amount of its 4.25% Convertible Senior Notes due 2014 (the “Underwritten Securities”) and, at the option of the Underwriters, up to an additional $48,750,000 principal amount of its 4.25% Convertible Senior Notes due 2014 (the “Option Securities”) if and to the extent that the Underwriters shall have determined to exercise the option to purchase such 4.25% Convertible Senior Notes due 2014 granted to the Underwriters in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities.” The Securities will be convertible into shares (the “Underlying Securities”) of common stock of the Company, par value $0.01 per share (the “Common Stock”). The Securities will be issued pursuant to